These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2007929)

  • 1. Neonatal surfactant therapy--where do we go from here?
    Martin RJ
    J Pediatr; 1991 Apr; 118(4 Pt 1):555-6. PubMed ID: 2007929
    [No Abstract]   [Full Text] [Related]  

  • 2. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
    Robertson B
    Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant in the preterm infant: what's going on.
    Dani C; Barp J; Berti E; Bertini G
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():3-5. PubMed ID: 19925357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On exogenous surfactant therapy.
    Merritt TA; Halliday HL
    Pediatr Pulmonol; 1992 Sep; 14(1):1-3. PubMed ID: 1437336
    [No Abstract]   [Full Text] [Related]  

  • 5. Minimally Invasive Surfactant Therapy to Prevent Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Isayama T
    JAMA; 2021 Dec; 326(24):2475-2476. PubMed ID: 34901990
    [No Abstract]   [Full Text] [Related]  

  • 6. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
    Engle WA;
    Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of artificial surfactant (ALEC) in the prophylaxis of neonatal respiratory distress syndrome.
    Morley CJ
    Eur Respir J Suppl; 1989 Mar; 3():81s-86s. PubMed ID: 2663001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal update: surfactant replacement therapy.
    Few BJ
    MCN Am J Matern Child Nurs; 1987; 12(2):129. PubMed ID: 3104720
    [No Abstract]   [Full Text] [Related]  

  • 9. Surfactant replacement in preterm infants with respiratory distress syndrome.
    Dani C
    Acta Biomed; 2012; 83 Suppl 1():17-20. PubMed ID: 23029871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory support in preterm infants at birth.
    ;
    Pediatrics; 2014 Jan; 133(1):171-4. PubMed ID: 24379228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
    Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
    J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic surfactants: the search goes on.
    Kattwinkel J
    Pediatrics; 2005 Apr; 115(4):1075-6. PubMed ID: 15805389
    [No Abstract]   [Full Text] [Related]  

  • 13. Surfactant therapy in the newborn.
    Lancet; 1985 Oct; 2(8460):867-8. PubMed ID: 2864581
    [No Abstract]   [Full Text] [Related]  

  • 14. [For or against the early use of nasal continuous positive pressure and exogenous surfactant in hyaline membrane disease. Physiopathologic arguments].
    Storme L; Truffert P; Rakza T; Lequien P
    Arch Pediatr; 1999 May; 6(5):549-55. PubMed ID: 10370813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myth: all surfactants are alike.
    Moya F; Javier MC
    Semin Fetal Neonatal Med; 2011 Oct; 16(5):269-74. PubMed ID: 21515101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will exogenous surfactant treat respiratory distress syndrome?
    Morley CJ
    Arch Dis Child; 1983 May; 58(5):321-3. PubMed ID: 6687991
    [No Abstract]   [Full Text] [Related]  

  • 17. Artificial surfactant therapy.
    Morley CJ; Davis JA
    Lancet; 1980 Feb; 1(8162):252. PubMed ID: 6101694
    [No Abstract]   [Full Text] [Related]  

  • 18. Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome.
    Zhou P; Han T
    JAMA; 2022 Apr; 327(16):1613-1614. PubMed ID: 35471523
    [No Abstract]   [Full Text] [Related]  

  • 19. Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome.
    Razak A
    JAMA; 2022 Apr; 327(16):1613. PubMed ID: 35471524
    [No Abstract]   [Full Text] [Related]  

  • 20. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
    Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.